KRAS and cancer: These recurring keywords not only reflect the primary research focus on KRAS mutations and immunotherapy in cancer but also provide insights into methodological aspects (“open-label”) and other molecular facets (“expression,” “clathrate”) that are pertinent to this line of inquiry.